BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 26047949)

  • 1. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.
    Zhang Y; Feng J; Wang Q; Zhao S; Xu J; Li H
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.
    Song Y; Zhao H; Liu J; Fang C; Miao R
    Inflammation; 2016 Apr; 39(2):663-71. PubMed ID: 26658749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model.
    Lee S; Kim W; Kang KP; Moon SO; Sung MJ; Kim DH; Kim HJ; Park SK
    Nephrol Dial Transplant; 2005 Jun; 20(6):1057-65. PubMed ID: 15797891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense.
    Zhang YF; Yang X; Zhang YJ; Sun YL; Zou XL; Kong QY; Dong XQ; Ye XQ; Yu XQ
    Am J Nephrol; 2006; 26(6):602-11. PubMed ID: 17183189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
    Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
    Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
    J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation.
    Bo QL; Chen YH; Yu Z; Fu L; Zhou Y; Zhang GB; Wang H; Zhang ZH; Xu DX
    Mol Cell Endocrinol; 2016 Mar; 423():51-9. PubMed ID: 26773728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
    Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
    Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
    Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
    Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.
    Zou XL; Pei DA; Yan JZ; Xu G; Wu P
    Int J Mol Sci; 2014 Apr; 15(4):6592-608. PubMed ID: 24747594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of peroxisome proliferator-activated receptor-γ/nuclear factor-ΚB transduction pathway on coagulation disorders induced by sepsis].
    Sun Y; Wang J; Yu L; Dai L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):520-4. PubMed ID: 26049195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.
    Liu N; Liu JT; Ji YY; Lu PP
    Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone protects rat liver against acute liver injury associated with the NF-κB signaling pathway.
    Chen W; Lin YJ; Zhou XY; Chen H; Jin Y
    Can J Physiol Pharmacol; 2016 Jan; 94(1):28-34. PubMed ID: 26394869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
    Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.